Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that was first approved for use in the United States in 1993. It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures - today it is also widely used to treat neuropathic pain. Gabapentin has some stark advantages ...
In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older. In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or...
Tanta University, Tanta, Elgharbia, Egypt
Northwell Health South Shore Surgery Center, Bay Shore, New York, United States
National Cancer Institute, Cairo, Egypt
Shamir Medical Center (Assaf Harofeh), Be'er Ya'aqov, Israel
Tanta University, Tanta, El-Gharbia, Egypt
Washington University School of Medicine, Saint Louis, Missouri, United States
SUNY Downstate Health Sciences University, Brooklyn, New York, United States
Mohawk Valley Health System - Womens Health Center, Utica, New York, United States
university of Miami, Miami, Florida, United States
University of Miami, Miami, Florida, United States
Gastrointestinal and Laparoscopic Surgery Unit, General Surgery Department, Tanta University Hospital, Tanta, Egypt, Tanta, Gharbiya, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.